Követés
David Christopher Currow
David Christopher Currow
Flinders University, University of Technology Sydney, Hull York Medical School
E-mail megerősítve itt: uts.edu.au
Cím
Hivatkozott rá
Hivatkozott rá
Év
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 …
C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ...
The Lancet 391 (10125), 1023-1075, 2018
44142018
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
M Arnold, MJ Rutherford, A Bardot, J Ferlay, TML Andersson, ...
The Lancet Oncology 20 (11), 1493-1505, 2019
8682019
A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style …
SM Parker, JM Clayton, K Hancock, S Walder, PN Butow, S Carrick, ...
Journal of pain and symptom management 34 (1), 81-93, 2007
6462007
Integration of oncology and palliative care: a Lancet Oncology Commission
S Kaasa, JH Loge, M Aapro, T Albreht, R Anderson, E Bruera, C Brunelli, ...
The lancet oncology 19 (11), e588-e653, 2018
6412018
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
AP Abernethy, DC Currow, P Frith, BS Fazekas, A McHugh, C Bui
Bmj 327 (7414), 523-528, 2003
6222003
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007
S Walters, C Maringe, MP Coleman, MD Peake, J Butler, N Young, ...
Thorax 68 (6), 551-564, 2013
5952013
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
JS Temel, AP Abernethy, DC Currow, J Friend, EM Duus, Y Yan, ...
The Lancet Oncology 17 (4), 519-531, 2016
5642016
Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial
AP Abernethy, CF McDonald, PA Frith, K Clark, JE Herndon, J Marcello, ...
The Lancet 376 (9743), 784-793, 2010
5592010
Physical, psychosocial, relationship, and economic burden of caring for people with cancer: a review
A Girgis, S Lambert, C Johnson, A Waller, D Currow
Journal of oncology practice 9 (4), 197-202, 2013
5482013
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial
JS Kutner, PJ Blatchford, DH Taylor, CS Ritchie, JH Bull, DL Fairclough, ...
JAMA internal medicine 175 (5), 691-700, 2015
5382015
The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]
AP Abernethy, T Shelby-James, BS Fazekas, D Woods, DC Currow
BMC palliative care 4, 1-12, 2005
5232005
Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review
K Hancock, JM Clayton, SM Parker, S Wal der, PN Butow, S Carrick, ...
Palliative medicine 21 (6), 507-517, 2007
5202007
Palliative cancer care a decade later: accomplishments, the need, next steps--from the American Society of Clinical Oncology
FD Ferris, E Bruera, N Cherny, C Cummings, D Currow, D Dudgeon, ...
J clin oncol 27 (18), 3052-3058, 2009
4882009
Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers
JM Clayton, KM Hancock, PN Butow, MHN Tattersall, DC Currow
The Medical Journal of Australia 186 (12), S77, 2007
4752007
Sustaining hope when communicating with terminally ill patients and their families: a systematic review
JM Clayton, K Hancock, S Parker, PN Butow, S Walder, S Carrick, ...
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2008
4242008
Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care
JM Clayton, PN Butow, MHN Tattersall, RJ Devine, JM Simpson, ...
Journal of Clinical Oncology 25 (6), 715-723, 2007
4062007
Health-related quality of life measured using the EQ-5D–5L: South Australian population norms
N McCaffrey, B Kaambwa, DC Currow, J Ratcliffe
Health and quality of life outcomes 14, 1-12, 2016
3642016
Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial
MR Agar, PG Lawlor, S Quinn, B Draper, GA Caplan, D Rowett, ...
JAMA internal medicine 177 (1), 34-42, 2017
3542017
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
MP Ekström, A Bornefalk-Hermansson, AP Abernethy, DC Currow
Bmj 348, 2014
3322014
Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study
DC Currow, C McDonald, S Oaten, B Kenny, P Allcroft, P Frith, M Briffa, ...
Journal of pain and symptom management 42 (3), 388-399, 2011
3312011
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20